20+ years leading highly innovative business with operational excellence. 8+ years of international regulatory experience and strategic development.
Chief Medical Officer
20+ years of clinical practice specializing in rare viral health conditions, immunology and degenerative health. Dr Mcdougall leads Immunacor's pioneering development strategies.
Sally duPre, PhD
Senior Research Scientist–
40+ years in biological research and development. Specializing in immune modulators & biochemistry.
30+ years as lab director for top tier hospitals, extensive experience with regulatory compliance and lab operations.
David Franco, CFO
Chief Financial Officer
25+ years as a CPA and CFO for rapid growth companies specializing in the medical industry.
Chairman - Business Development
Executive Chairman of multiple venture funds investing in hyper innovative and disruptive businesses. Mr. Hinds brings connections and 30+ years of business development experience to Immunacor.
30+ years early venture capital experience. Managed $2 billion+.
Kenneth Hunter, PhD
Emeritus Professor of Immunology & Head of applied research. Expert in Immune modulation, 60+ published papers.